The Healthy @Reader's Digest

I Was on 11 Medications for Autoimmune Symptoms and Chronic Pain—Then I Started Red Light Therapy, and My Reality Changed

After two decades of surgeries, prescriptions, and debilitating symptoms, this mom discovered a treatment that significantly ...
Live Science on MSN

Tiny implant 'speaks' to the brain with LED light

By directly communicating with the brain, a new wireless device could someday help restore lost senses or manage pain without medications, its developers say.
The Blogs | The Times of IsraelOpinion

Ignore Somaliland and Imperil NATO

Somaliland’s unratified union parallels the Baltic sham votes. Denying Somaliland validates coerced unions, weakening the ...

Why SMX’s Partnerships Expand Value Faster Than Its Cost Base

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / In early-stage companies, partnerships are often treated as marketing events. Logos get added to slides. Press releases get circulated. Little ...

SMX Is Being Valued By Monetizing Certainty, Not Sustainability Narratives

NEW YORK, NY / ACCESS Newswire / December 24, 2025 / SMX’s valuation story is one that the markets are finally coming to understand: monetization. Not revenue in the narrow, quarterly sense, but how ...

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung ...

Regeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...